BALAXI PHARMACEUTICALS logo

BALAXI PHARMACEUTICALS MD, chairman, board of directors and AGM

NSE: BALAXIPharmaceuticals & BiotechnologySmall Cap

Formerly Balaxi Ventures
Last close ₹20.91down ₹0.09 (0.43%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹21.00.

52-week range of traded prices to 23 Oct 2026
₹15.20Low, 27 Mar 2026₹43.85High, 4 Nov 2025
Market cap
₹115 Cr2,722nd largest listed
P/E
47.6
P/B
0.5
Dividend yield
Nonein the last 12 months
ROE
1.0%
ROCE
2.1%
Debt to equity
0.22
Volume, NSE
40,13985.6% delivered

BALAXI PHARMACEUTICALS board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorASHISH MAHESHWARI
  • Company Secretary and Compliance OfficerAman Purohit

6 directors4 independent1 executive1 non-executive

  • ASHISH MAHESHWARI · Chairperson and managing directorExecutive · joined May 2017 · reappointed May 2022 · 1 listed board · 1 committee seat
  • MINOSHI MAHESHWARINon-executive · joined Feb 2018 · reappointed Aug 2025 · 1 listed board · 1 committee seat
  • KUNAL MAHENDRA BHAKTAIndependent · joined May 2017 · reappointed May 2022 · 109 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
  • GANDHI GAMJIIndependent · joined May 2017 · reappointed May 2022 · 109 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • MANGINA SRINIVAS RAOIndependent · joined Sep 2020 · reappointed Sep 2023 · 69 months as independent · 7 listed boards · 7 as independent · 10 committee seats, 3 as chair
  • AKSHITA OSTWALIndependent · joined Sep 2024 · 21 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 28 May 20266 of 6 present4 independent · 63 days in between
    • 25 Mar 20266 of 6 present4 independent · 55 days in between
    • 28 Jan 20266 of 6 present4 independent

  • Audit Committee

    Chair KUNAL MAHENDRA BHAKTA

    GANDHI GAMJI, ASHISH MAHESHWARI, MANGINA SRINIVAS RAO

    • 28 May 20264 of 4 present3 independent · 119 days in between
    • 28 Jan 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair KUNAL MAHENDRA BHAKTA

    GANDHI GAMJI, MINOSHI MAHESHWARI

    • 28 May 20263 of 3 present2 independent · 63 days in between
    • 25 Mar 20263 of 3 present2 independent · 55 days in between
    • 28 Jan 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair KUNAL MAHENDRA BHAKTA

    GANDHI GAMJI, MINOSHI MAHESHWARI

    No meeting listed in the filing.

  • Risk Management Committee

    Chair ASHISH MAHESHWARI

    GANDHI GAMJI, AMOL ANAND MANTRI

    • 28 May 20262 of 2 present1 independent · 202 days in between
    • 6 Nov 20252 of 2 present1 independent

  • Corporate Social Responsibility Committee

    Chair MINOSHI MAHESHWARI

    ASHISH MAHESHWARI, GANDHI GAMJI

    • 28 May 20263 of 3 present1 independent · 295 days in between
    • 5 Aug 20253 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • P Murali & CoPeer-review certificate valid to Mar 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

BALAXI PHARMACEUTICALS AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.BALAXI PHARMACEUTICALS dividend history

Annual general meeting, 24 Aug 2026

14,729 shareholders on the register on 17 Aug 2026; present: 3 promoters and 49 others; votes counted by YOGINDUNATH S / BVR & ASSOCIATES COMPANY SECRETARIES LLP.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone Financial Statements
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 72.29% · promoters 100.00% · institutions 0.00% · other public 20.03%

  2. Adoption of Audited Consolidated Financial Statements.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 72.29% · promoters 100.00% · institutions 0.00% · other public 20.03%

  3. Re-appointment of Mrs. Minoshi Maheshwari (DIN: 01575975) as a Director, liable to retire by rotation.
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 72.29% · promoters 100.00% · institutions 0.00% · other public 20.03%

  4. Re-appointment of Ms. Akshita Ostwal (DIN: 10026552), as an Independent Director of the Company.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 72.29% · promoters 100.00% · institutions 0.00% · other public 20.03%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Aug 2025, 4 resolutions

14,983 shareholders on the register on 25 Aug 2025; present: 3 promoters and 57 others; votes counted by Yogindunath S / BVR & Associates Company Secretaries LLP.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone Financial Statements
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 69.81% · promoters 100.00% · institutions 0.00% · other public 12.52%

  2. Adoption of Audited Consolidated Financial Statements
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 69.81% · promoters 100.00% · institutions 0.00% · other public 12.52%

  3. Re-appointment of Mrs.Minoshi Maheshwari (DIN:01575975) as a Director,liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 69.81% · promoters 100.00% · institutions 0.00% · other public 12.52%

  4. Appointment of Secretarial Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 69.81% · promoters 100.00% · institutions 0.00% · other public 12.52%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Mar 2025, 1 resolution

9,326 shareholders on the register on 21 Feb 2025; votes counted by Mr.Yogindunath S / BVR & Associates, Company Secretaries LLP.The company's voting result (opens in a new tab)

  1. Approval for payment of Remuneration to Mr.Ashish Maheshwari(DIN:01575984),Managing Director of the Company
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 77.58% · promoters 100.00% · institutions 49.62% · other public 19.40%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 6 Nov 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Ms. Akshita Surana as Non- Executive Independent Director
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.61%

    Turnout: all 66.03% · promoters 100.00% · institutions 0.00% · other public 0.22%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 23 Aug 2024, 3 resolutions

Present: 3 promoters and 35 others.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone Financial Statements.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 68.41% · promoters 100.00% · institutions 0.00% · other public 14.00%

  2. Adoption of Audited consolidated Financial Statements.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 68.41% · promoters 100.00% · institutions 0.00% · other public 14.00%

  3. Re-Appointment of Mrs.Minoshi Maheshwari as a director liable to retire by rotation
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.27%

    Turnout: all 68.41% · promoters 100.00% · institutions 0.00% · other public 14.00%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 16 Apr 2024, 2 resolutions

Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)

  1. Sub-division/ Split of Equity Shares of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 75.53% · promoters 100.00% · institutions 24.63% · other public 23.27%

  2. Alteratio of Memorandum of Association of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 75.53% · promoters 100.00% · institutions 24.63% · other public 23.27%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Aug 2023, 5 resolutions

Present: 3 promoters and 46 others.The company's voting result (opens in a new tab)

  1. Adoption of Audited Standalone Financial Statements.
    Ordinary
    98.78% for1.22% against

    Against: promoters 0.00% · institutions 0.00% · other public 39.15%

    Turnout: all 92.69% · promoters 100.00% · institutions 99.86% · other public 28.39%

  2. Adoption of Audited Consolidated Financial Statements.
    Ordinary
    98.78% for1.22% against

    Against: promoters 0.00% · institutions 0.00% · other public 39.15%

    Turnout: all 92.69% · promoters 100.00% · institutions 99.86% · other public 28.39%

  3. Re-appointment of Mrs. Minoshi Maheshwari (DIN: 01575975) as a director, liable to retire by rotation.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 92.69% · promoters 100.00% · institutions 99.86% · other public 28.39%

  4. Re-appointment of M/s P. Murali & Co., Chartered Accountants, as Statutory Auditors of the Company.
    Ordinary
    98.78% for1.22% against

    Against: promoters 0.00% · institutions 0.00% · other public 39.16%

    Turnout: all 92.69% · promoters 100.00% · institutions 99.86% · other public 28.39%

  5. Re-appointment of Mr. Mangina Srinivas Rao (DIN: 08095079) as an Independent Director of the Company.
    Special
    98.78% for1.22% against

    Against: promoters 0.00% · institutions 0.00% · other public 39.16%

    Turnout: all 92.69% · promoters 100.00% · institutions 99.86% · other public 28.39%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 Mar 2023, 1 resolution

Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)

  1. Re-appointment of Mrs. Purnima Singh Kamble (DIN: 00241708) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 92.31% · promoters 100.00% · institutions 99.86% · other public 18.33%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Mar 2026. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.

RaisedAmount raisedForSet asideSpentSpent elsewhere
Preferential IssuesOct 2022–The proceeds of the preferential issue shall be utilized to meet the capital expenditure requirements to support the construction of the Company’s first pharmaceutical formulation plant, being set up at Jadcherla, Hyderabad. Further, it may be utilized to meet working capital requirements and general corporate purposes and may also utilize to undertake any additional business activities under the main objects clause of the Memorandum of Association of the Company.––No
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.